Not registered yet? Get a free account.

Sign Up
search icon cancel icon
Rexcel Pharmaceuticals Limited Location T. Score People Network Registered Details
We are excited to bring you Tofler 2.0! Being new, there might be a few hiccups. Please bear with us.

REXCEL PHARMACEUTICALS LIMITED

Amalgamated
Updated: 30 Nov 2023

Rexcel Pharmaceuticals Limited, was an unlisted public company incorporated on 03 March, 1997. It is classified as a public limited company and is located in , Delhi. It's authorized share capital was INR 15.00 cr and the total paid-up capital was INR 12.50 cr.

The current status of Rexcel Pharmaceuticals Limited is - Amalgamated.

Read more

Industry

Manufacturing of Pharmaceuticals
Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales
9.29%
₹ GET PRO
EBITDA
7.69%
₹ GET PRO
Net Profit
-68.97%
₹ GET PRO
Networth
2.15%
₹ GET PRO
Borrowings
6.23%
₹ GET PRO
Assets
5.07%
₹ GET PRO
Gross Margin
5.57
GET PRO%
Operating Margin
-0.31
GET PRO%
Net Profit Margin
-8.37
GET PRO%
Return on Equity
-8.01
GET PRO%
ROCE
-0.76
GET PRO%
Debt to Equity
0.01
GET PRO
Sales
Mar 2024
Net worth
Mar 2024

Locations

indian flag India (1)
State Type Address

location icon Locations on Map

Map placeholder

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Financial Highlights

** All numbers in INR crores
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%
** All numbers in INR crores
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Profit & Loss

%
** All numbers in INR crores
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales + GET PRO GET PRO GET PRO GET PRO GET PRO
Sales growth % GET PRO GET PRO GET PRO GET PRO GET PRO
Expenses + GET PRO GET PRO GET PRO GET PRO GET PRO
Cost of goods GET PRO GET PRO GET PRO GET PRO GET PRO
Employee cost GET PRO GET PRO GET PRO GET PRO GET PRO
Other costs GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit + GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin % GET PRO GET PRO GET PRO GET PRO GET PRO
Other income GET PRO GET PRO GET PRO GET PRO GET PRO
Interest GET PRO GET PRO GET PRO GET PRO GET PRO
Depreciation GET PRO GET PRO GET PRO GET PRO GET PRO
Exceptional items GET PRO GET PRO GET PRO GET PRO GET PRO
Profit before tax GET PRO GET PRO GET PRO GET PRO GET PRO
Tax GET PRO GET PRO GET PRO GET PRO GET PRO
Profit - disc. ops GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin % GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Revenue from operations

Ratios

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Solvency +
Total Debt/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Net Debt/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Total Debt/Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total Assets/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Liquidity +
Current Ratio GET PRO GET PRO GET PRO GET PRO GET PRO
Quick Ratio GET PRO GET PRO GET PRO GET PRO GET PRO
Interest Coverage GET PRO GET PRO GET PRO GET PRO GET PRO
Performance
Gross Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Return +
Return on Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Pre-tax ROCE GET PRO GET PRO GET PRO GET PRO GET PRO
Return on Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Pre-tax ROIC GET PRO GET PRO GET PRO GET PRO GET PRO
Efficiency +
Days Payable GET PRO GET PRO GET PRO GET PRO GET PRO
Days Inventory GET PRO GET PRO GET PRO GET PRO GET PRO
Days Receivable GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Asset Turnover GET PRO GET PRO GET PRO GET PRO GET PRO
Total Asset Turnover GET PRO GET PRO GET PRO GET PRO GET PRO
Working Capital
Cash Conversion Cycle GET PRO GET PRO GET PRO GET PRO GET PRO
Working Capital Days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Ratios

Current ratio
Debt/equity ratio

People

Designation Name DIN/PAN Tenure
Director Sandeep Mehandroo 00123248 17 years
Director Sanjeev Indravadan Dani 00258927 19 years
Director Ranjit Kohli 01517638 13 years
Director Ashwani Kumar Malhotra 03142307 14 years

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
SUN PHARMA MEDISALES PRIVATE LIMITED
Amalgamated
10.0 L 1 Gujarat
GUFIC PHARMA LIMITED
Amalgamated
5.0 L 1 Gujarat
RANBAXY DRUGS LIMITED
Amalgamated
3.1 Cr 1 Gujarat
VIDYUT INVESTMENTS LIMITED
Active
25.0 Cr 1 Punjab
SERENDIP LEISURE AND RECREATION PRIVATE LIMITED
Active
37.9 L 1 Delhi
RANBAXY LIFE SCIENCES RESEARCH LIMITED
Amalgamated
5.1 Cr 1 Punjab
SOLUS PHARMACEUTICALS LIMITED
Amalgamated
14.9 Cr 4 Delhi
RANBAXY SEZ LIMITED
Amalgamated
5.0 L 1 Punjab
RANBAXY DRUGS AND CHEMICALS COMPANY
Amalgamated
6.2 Cr 2 Delhi
IMPICO ASSOCIATES LLP
Active
10,000.0 1 Delhi
MENSK MANAGEMENT CONSULTANTS LLP
Active
10,000.0 1 Delhi

Registered Details

CIN

U24231DL1997PLC085491

PAN

-

Incorporation

1997, 27.7 years

Company Email

secretarial@ranbaxy.com

Paid up Capital

₹ 12.5 Cr

Authorised Capital

₹ 15.0 Cr

AGM

31 Jun 2024

Type

Public
Non-government Company

Last Balance Sheet Date
Reconfirm refresh img

Dec 2011 Updated on : 30 Nov 2023
* There is the date provided by MCA, but availability for this year is not guaranteed.

FAQ - REXCEL PHARMACEUTICALS LIMITED

What is the incorporation date of REXCEL PHARMACEUTICALS LIMITED?

plus icon

The incorporation date of REXCEL PHARMACEUTICALS LIMITED is 03 March, 1997

What is the authorized share capital of REXCEL PHARMACEUTICALS LIMITED?

plus icon

The authorized share capital of REXCEL PHARMACEUTICALS LIMITED is INR ₹ 15.0 Cr.

What is the paid-up capital of REXCEL PHARMACEUTICALS LIMITED?

plus icon

The paid-up capital of REXCEL PHARMACEUTICALS LIMITED is INR ₹ 12.5 Cr.

What is the registered address of REXCEL PHARMACEUTICALS LIMITED?

plus icon

The registered address of REXCEL PHARMACEUTICALS LIMITED is 12TH FLOOR, DEVIKA TOWER, NEHRU PLACE NEW DELHI South Delhi Delhi - 110019

What is the CIN number of REXCEL PHARMACEUTICALS LIMITED?

plus icon

The CIN number of REXCEL PHARMACEUTICALS LIMITED is U24231DL1997PLC085491.

Smart Suggestions

  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Goa
  • Madhya Pradesh
  • Kerala
  • Gujarat
  • Andhra Pradesh
  • Telangana
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More